Skip to content

Integrated Suicide & Trauma Therapy for Suicide Risk

Using Integrated Suicide and Trauma Therapy to Reduce Suicide Risk Among Adults With a History of Childhood Trauma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05613972
Acronym
ISTT
Enrollment
20
Registered
2022-11-14
Start date
2025-12-08
Completion date
2027-07-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder, Suicide, Trauma

Keywords

Childhood trauma, Early life adversity, Adverse childhood experiences, Suicide intervention, Psychotherapy

Brief summary

The investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of ISTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.

Detailed description

In the last 10 years, despite available treatments, suicide rates have not significantly decreased, and individuals who have experienced any type of childhood maltreatment are at increased odds for suicide attempt. Effective suicide prevention requires learning skills to cope with suicidality in addition to addressing the antecedent factors that contribute to suicide risk. In the context of those with childhood trauma and suicidality, addressing antecedent factors may require treatments that target symptoms associated with developmental trauma. Thus, the investigators have developed an integrated suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of BSTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.

Interventions

OTHERIntegrated Suicide and Trauma Therapy

12-week trauma therapy for suicide risk

Sponsors

Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Beck Scale for Suicidal Ideation \> 10 * Presence of childhood trauma defined by a minimum moderate score on any of the Childhood Trauma Questionnaire subscales (emotional abuse, physical, abuse, sexual abuse, emotional neglect, and physical neglect * any psychiatric diagnosis as long as there are no impairments that limit consent or understanding of ISTT (e.g. active psychosis) * Ability to provide informed consent * Not receiving other psychotherapy concurrently * Ability to undergo psychotherapy in English

Exclusion criteria

* The presence of cognitive impairment and/or active psychosis that would limit consent or understanding of ISTT * Unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Beck Scale for Suicide Ideation (BSS) scoreFrom baseline to 1 week post-therapyBeck Scale for Suicide Ideation is a 21-item self-report scale that quantifies suicidal ideation. Items are scored 0 to 2 and yield a total score ranging from 0 to 38. Higher scores reflect greater severity of suicidal ideation.
Feasibility and acceptability of ISTTFrom baseline to 1 week post-therapyAcceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Feasibility of Intervention Measure (FIM), in addition to a feedback survey and interview created in-house with questions designed to collect quantitative and qualitative feedback from participants with respect to the feasibility and acceptability of the BSTT intervention.

Secondary

MeasureTime frameDescription
Change in Generalized Anxiety Disorder 7-item scale (GAD-7) scoreFrom baseline to 1-week post therapyThe GAD-7 is a brief 7-item self-report scale measuring anxiety symptoms. Total scores range from 0 to 21, with higher scores reflecting more severe anxiety.
Change in Quick Inventory of Depressive Symptoms 16-item scale (QIDS) scoreFrom baseline to 1 week post-therapyThe QIDS is a 16-item validated depression scale. Total scores range from 0-27, with higher scores reflecting more severe depression.
Change in Difficulties in Emotion Regulation Scale 36-item scale (DERS) scoreFrom baseline to 1 week post-therapyThe DERS is a 36-item validated scale measuring six aspects of emotion regulation. The DERS is comprised of 6 subscales, where higher scores are reflective of greater difficulties in emotion regulation. The DERS is often analyzed by percentile.

Countries

Canada

Contacts

CONTACTSakina Rizvi, PhD,MACP,RP
rizvisa@smh.ca416-864-6060
CONTACTAleksandra Lalovic, PhD,MEd,RP
Aleksandra.Lalovic@unityhealth.to416-864-6060
PRINCIPAL_INVESTIGATORSakina Rizvi, PhD,MACP,RP

Unity Health Toronto

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026